Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
โ‚ฌ3.97 M
Marketcap
0,30ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Mallinckrodt Pharmaceuticals (MNK)

Earnings in 2023 (TTM): -โ‚ฌ1.1 Billion

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ1.93 Billion. In 2022 the company made an earning of -โ‚ฌ1.29 Billion a decrease over its 2021 earnings that were of -โ‚ฌ0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ1.1 Billion-15.09%
2022 -โ‚ฌ1.29 Billion76.14%
2021 -โ‚ฌ0.73 Billion-13.63%
2020 -โ‚ฌ0.85 Billion-39.63%
2019 -โ‚ฌ1.4 Billion-61.51%
2018 -โ‚ฌ3.64 Billion-6812.18%
2017 โ‚ฌ54.18 M-185.79%
2016 -โ‚ฌ63.16 Million-131.27%
2015 โ‚ฌ0.20 B-166.82%
2014 -โ‚ฌ0.31 Billion-319.69%
2013 โ‚ฌ0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ15.34 B-1,616.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.19 Billion-81.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.25 Billion-75.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ7.47 B-839.07%๐Ÿ‡บ๐Ÿ‡ธ USA